Avinger announces full commercial launch of lightbox 3

Redwood city, ca / accesswire / april 19, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced full commercial availability of its new lightbox 3 imaging console designed to enhance the user experience and drive faster adoption at new hospital sites. avinger received 510(k) clearance for the lightbox 3 from the u.s. food & drug administration (fda) in january, and conducted a successful limited launch with key opinion leaders in february and march.
AVGR Ratings Summary
AVGR Quant Ranking